Food and Drugs Regulations.
Country
Type of law
Regulation
Abstract
These Regulations lay down rules for the administration, standards, manufacturing, sampling, labelling, packaging, sales, storage, certification of food and drugs. These Regulations, where applicable, prescribe the standards of composition, strength, potency, purity, quality or other property of the article of food, drug, cosmetic or device to which they refer, and approve the advertisement of any food, drug, cosmetic or device only if they are in compliance with the Act and these Regulations. Furthermore, an inspector may be appointed by the Ministry of Health to carry out duties, such as inspecting the premises, and taking samples of imported food. Part II to these Regulations puts emphasis on food safety and provides rules for food additives, artificial sweeteners, sugar, alcoholic beverages, flavourings, food colour, treated food, food preservatives, packaging, storage, and labelling of food and the information to be carried on label, and exceptions to the list of ingredients and label declaration. Moreover, Part II also sets out provisions on the adulteration of food; the prohibition to prepare, pack, store or transport any food intended for sale which is injurious to the health of a consumer; the prohibition on using water other than potable water as an ingredient in the manufacture or preparation of any food; poisonous substances specified in Part III of Second Schedule; and food standards listed in Part IV of Second Schedule.
The requirements for labelling of drugs are prescribed in Part III, and the advertisement of a Third Schedule Drug or a controlled drug to the general public for human use is prohibited. In addition to that, it is underlined that the drugs listed in Third Schedule shall only be sold by prescription by the practitioner, and drugs listed in Part II of Third Schedule are not suitable for treating humans, such as antibiotic preparation for the treatment of cattle, and therefore their labels or packages should insert warnings in this manner and the residues which remain in meat, meat by-products, eggs or milk from animals to which the drug has been administered, shall be within the limits prescribed by these Regulations. Regulation 88 lists the substances which are classified as controlled drugs and these controlled drugs shall only be manufactured, sold, imported and exported by a licensed dealer. With respect to drugs, these Regulations set out the suitable conditions for manufacturing, packaging, preserving, storing, testing, labelling, sales, advertisement, and importation of a new drug; the procedures and principles for the issuance of licence to manufacture or import a new drug in Guyana and for its sales and advertisement; and the obligation for reporting any unexpected side effects, injury, toxicity or sensitivity reaction of a drug manufactured or imported in Guyana. These Regulations shall not apply to any antibiotic which is imported, exported, manufactured, dispensed or sold in accordance with the Antibiotic Act.
The requirements for labelling of drugs are prescribed in Part III, and the advertisement of a Third Schedule Drug or a controlled drug to the general public for human use is prohibited. In addition to that, it is underlined that the drugs listed in Third Schedule shall only be sold by prescription by the practitioner, and drugs listed in Part II of Third Schedule are not suitable for treating humans, such as antibiotic preparation for the treatment of cattle, and therefore their labels or packages should insert warnings in this manner and the residues which remain in meat, meat by-products, eggs or milk from animals to which the drug has been administered, shall be within the limits prescribed by these Regulations. Regulation 88 lists the substances which are classified as controlled drugs and these controlled drugs shall only be manufactured, sold, imported and exported by a licensed dealer. With respect to drugs, these Regulations set out the suitable conditions for manufacturing, packaging, preserving, storing, testing, labelling, sales, advertisement, and importation of a new drug; the procedures and principles for the issuance of licence to manufacture or import a new drug in Guyana and for its sales and advertisement; and the obligation for reporting any unexpected side effects, injury, toxicity or sensitivity reaction of a drug manufactured or imported in Guyana. These Regulations shall not apply to any antibiotic which is imported, exported, manufactured, dispensed or sold in accordance with the Antibiotic Act.
Attached files
Date of text
Repealed
No
Source language
English
Legislation Amendment
No
Implements